Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
暂无分享,去创建一个
Joakim Dillner | Jack Cuzick | Marc Arbyn | Guglielmo Ronco | Vivien Tsu | J. Cuzick | J. Dillner | C. Meijer | G. Ronco | R. Sankaranarayanan | M. Arbyn | Rengaswamy Sankaranarayanan | V. Tsu | Chris J L M Meijer | Marie-Helene Mayrand | M. Mayrand
[1] Louise Kuhn,et al. Direct visual inspection for cervical cancer screening , 2002, Cancer.
[2] P. Snijders,et al. Implementation of human papillomavirus testing in cervical screening without a concomitant decrease in participation rate , 2006, Journal of Clinical Pathology.
[3] M. van der Aa,et al. Mass screening programmes and trends in cervical cancer in Finland and the Netherlands , 2007, International journal of cancer.
[4] T. Wright,et al. Women's desired information about human papillomavirus , 2004, Cancer.
[5] J. Berkhof,et al. Human papillomavirus testing on self‐sampled cervicovaginal brushes: An effective alternative to protect nonresponders in cervical screening programs , 2007, International journal of cancer.
[6] Joakim Dillner,et al. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. , 2004, Journal of the National Cancer Institute.
[7] Joakim Dillner,et al. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. , 2007, The New England journal of medicine.
[8] Thomas C Wright,et al. Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial. , 2005, JAMA.
[9] J. Berkhof,et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial , 2007, The Lancet.
[10] J. Wardle,et al. Social and psychological impact of HPV testing in cervical screening: a qualitative study , 2006, Sexually Transmitted Infections.
[11] S. Goldie,et al. HPV Communication: Review of Existing Research and Recommendations for Patient Education , 2004, CA: a cancer journal for clinicians.
[12] H. Kitchener,et al. Effect of testing for human papillomavirus as a triage during screening for cervical cancer: observational before and after study , 2006, BMJ : British Medical Journal.
[13] T. Rohan,et al. Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. , 2003, Journal of the National Cancer Institute.
[14] J. Cuzick,et al. HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology. , 2007, European journal of cancer.
[15] Colposcopy at a crossroads. , 2006 .
[16] Eric Lucas,et al. Accuracy of visual screening for cervical neoplasia: Results from an IARC multicentre study in India and Africa , 2004, International journal of cancer.
[17] Marc Arbyn,et al. Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India , 2008, International journal of cancer.
[18] B. Thomsen,et al. Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study , 2002, BMJ : British Medical Journal.
[19] Jose Jeronimo,et al. Human papillomavirus and cervical cancer , 2007, The Lancet.
[20] J. Wardle,et al. Human papillomavirus testing by self-sampling: assessment of accuracy in an unsupervised clinical setting , 2007, Journal of medical screening.
[21] J. Wardle,et al. Awareness of human papillomavirus among women attending a well woman clinic , 2003, Sexually transmitted infections.
[22] K. Ault. Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials , 2007, The Lancet.
[23] M. von Knebel Doeberitz,et al. Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison. , 1999, Journal of clinical pathology.
[24] J. Wardle,et al. Attitudes towards HPV testing: a qualitative study of beliefs among Indian, Pakistani, African-Caribbean and white British women in the UK , 2003, British Journal of Cancer.
[25] S. Tatti,et al. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America: This report refers to partial results from the LAMS (Latin AMerican Screening) study , 2005 .
[26] J. Berkhof,et al. High Concordance of Results of Testing for Human Papillomavirus in Cervicovaginal Samples Collected by Two Methods, with Comparison of a Novel Self-Sampling Device to a Conventional Endocervical Brush , 2006, Journal of Clinical Microbiology.
[27] J. Dillner,et al. Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses. , 2006, Vaccine.
[28] Sue J Goldie,et al. Cost-effectiveness of cervical-cancer screening in five developing countries. , 2005, The New England journal of medicine.
[29] D. Stewart,et al. Knowledge about human papillomavirus among adolescents. , 2000, Journal of lower genital tract disease.
[30] U Menon,et al. Management of women who test positive for high-risk types of human papillomavirus: the HART study , 2003, The Lancet.
[31] C. Wheeler,et al. New technologies in cervical cancer screening. , 2008, Vaccine.
[32] J. Cuzick,et al. Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group. , 1996, British Journal of Cancer.
[33] C. Clavel,et al. Negative human papillomavirus testing in normal smears selects a population at low risk for developing high-grade cervical lesions , 2004, British Journal of Cancer.
[34] J. Fitzgerald,et al. Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis , 2005, Sexually Transmitted Infections.
[35] C. Meijer,et al. Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women. , 2002, Journal of clinical pathology.
[36] R. Prado,et al. Effective cervical cytology screening programmes in middle-income countries: the Chilean experience. , 2005, Cancer detection and prevention.
[37] R. Sankaranarayanan,et al. Training for cervical cancer prevention programs in low‐resource settings: Focus on visual inspection with acetic acid and cryotherapy , 2005, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[38] J. Dillner,et al. Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence. , 2005, Gynecologic oncology.
[39] Marc Arbyn,et al. Liquid Compared With Conventional Cervical Cytology: A Systematic Review and Meta-analysis , 2008, Obstetrics and gynecology.
[40] J. Wardle,et al. Awareness of risk factors for cancer among British adults. , 2001, Public health.
[41] P. Sasieni,et al. Effect of screening on cervical cancer mortality in England and Wales: analysis of trends with an age period cohort model , 1999, BMJ.
[42] L. Gaffikin,et al. Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: a demonstration project , 2003, The Lancet.
[43] J. Cuzick,et al. Long‐term follow‐up of cervical abnormalities among women screened by HPV testing and cytology—Results from the Hammersmith study , 2008, International journal of cancer.
[44] Rajaraman Swaminathan,et al. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial , 2007, The Lancet.
[45] D. Parkin,et al. A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India , 2005, International journal of cancer.
[46] David R. Scott,et al. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. , 2003, Journal of the National Cancer Institute.
[47] L Gaffikin,et al. A critical assessment of screening methods for cervical neoplasia , 2005, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[48] P. Snijders,et al. Long-term protective effect of high-risk human papillomavirus testing in population-based cervical screening , 2005, British Journal of Cancer.